1--gmt-pres english-mstr
TRANSCRIPT
GlobalMed Technologies Inc.
Medical Technologies for the Future Generation
A Company dedicated to the Treatments and Cure
of Catastrophic Diseases
Who is GlobalMed Tech, (GMT)
• GMT is a Bio Medical Technology Company.• GMT has developed a treatment modality which
effectively inactivates the HIV virus.• GMT has Government approval to conduct Controlled
Clinical Trials on 100 subjects in South America.• GMT has patented it’s process and products
worldwide. • GMT Manufactures 5 Main Components:• PCI-1 Hemoirradiator• The GMT - Electronic Master Control Card• GMT Proprietary Software• Patient Intelli - Flash drive Software• The GMT – Cuvette, ( Irradiation Chamber )
PCITHE PROCESS OF HEMOIRRADIATION.
• PCI IS THE PROCESS OF EXPOSING A CERTAIN QUANTITY OF BLOOD TO ULTRAVIOLET IRRADIATION VIA A STERILE CLOSED CIRCUIT, CALLED A CUVETTE OR IRRADIATION CHAMBER.
• THE BLOOD NEVER COMES IN CONTACT WITH THE AMBIENT ENVIRONMENT.
FUNCTION• AS IN ANY FORM OF THERAPY, THE SUCCESS
OF HEMOIRRADIATION IS DEPENDANT ON THE DOSAGE ADMINISTERED.
• AND• THE CURATIVE PROPERTIES IN VIVO IS
DERIVED FROM THE ACTIVATION AND STIMULATORY EFFECT UPON CELLS AND MOLECULES WHICH COMPOSE HUMAN BLOOD.
NIELS FINSEN
• FATHER OF PHOTOTHERAPY:
• Won Nobel Prize in Physiology & Medicine in 1903 “In recognition of his contribution to the treatment of diseases, especially Lupus Vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science“
• Dr. Finsen’s contribution to medicine is unparallel. He treated 300 patients with Lupus Vulgaris and demonstrated, 100% success rates. Today, we have nothing in our arsenal of medications that can produce such results.
Lester Edblom, medical student and Dr. Emmet Knott scientist, developed the first Hemoirradiator vacuum extraction system and Cuvette. The first Patent was issued in the US for a UV-Irradiator. September 11, 1928.Thousands of people were treated between the 1930’s up to 1969 with a 98% success rate..
Emmet Knott Irradiator.
EUMATRON
HEMOIRRADIATOR FROM GERMANY.
UTILIZED IN THOUSANDS OF MEDICAL CENTERS
IN EUROPE.
PTX4PHOTONIC PUMP
USA.NOT-FDA APPROVEDUTILIZED IN VARIOUS
ALTERNATIVE CENTERS IN THE
US
Baxter Fenwal Plasma
Separator. Utilized in the treatment of Scleroderma In San Vicente
Hospital Medellin, Colombia.
Treatment of Scleroderma -LupusTime of Tx. 5 hours. Cost: 2,000 to 2,500
US
THERAKOSJOHNSON & JOHNSON
Ultraviolet A Irradiator
Irradiator developed by Dr. Elderson and
utilized in clinical trials on AIDS Related ARC patients at Columbia University in 1990. Four subjects were registered as SERO
Negative after 5 to 19 Sessions.
Therakos. Time of Tx. 5 hours. Cost: 5,000 US
GlobalMed Technologies:
• PCI-1 Hemoirradiator• GMT- Cuvette (Irradiation Chamber)• Electronic Master Control Card• Electronic UV Detector• GMT Proprietary Software• Patient Inteli - Flash drive Software
PCI-1 GLOBALMEDTime of Tx. 25 minutes Cost: $75.00 )
GMT-PCI-1Bar Code Scanner
UVC Irradiation Bulb
Automatic Peristalsis Pump
Inteliflash-Card
LCD
Keyboard
UV protection Lid
GMT-Cuvette
Utilized during Treatments.Developed and Manufactured by
GMT.Patent Registered Worldwide.
GMT -Cuvette (Irradiation Chamber)
Prototype
Blood Banks
Human
GMT -Cuvette (Irradiation Chamber)
Quartz Glass
External Body
Top
O-Ring 1
O-Ring 2
GMT –Kit
Hep-Loc IV Catheter Placement.,
Used to extract and re infuse patients blood during
treatment.
Placement of
GMT-Hep-Loc
Blood Extraction
Process• Patient sits comfortably and may watch television, read or listen to music during their sessions.
•Up to 300ml of blood is extracted.
• Time of Treatment: Extraction 7-10 min.
Irradiation 5 minRe Infusion 7-10 min
• Total Time : 19-25 min
Commencement of Treatment. Blood begins to
enter Cuvette.
Irradiation Process.The blood is propelled by the Peristaltic
Pump via the Irradiation Chamber (Cuvette) where the blood is irradiated with the precise amount of UV Dosage. After irradiation the blood continues to
the secondary Blood Bag and from there is returned via a Blood Administration Kit
with a 70um Filter.
Re-Infusion Process
Government Approved Clinical Study in the
Republic Dominican with 36 Patients living with
HIV/AIDS
TREATMENT PROCESS GMT. PROCESS OF BLOOD EXTRACTION.
GlobalMed
Process of
IrradiationTime: 25 minutes
Cost $75.00 US/Kit.
TREATMENT CENTER
Bacterial Membrane Destruction
UV destroys a Bacteria's Membrane there by Inactivating the Bacteria
Before After
Virus Destruction
2 Hours 4 Hours 6 Hours
The destruction of a Virus is achieved by Fragmentation which Inactivates the
Virus.
Destruction of Fungus
The Destruction of Fungus is achieved by the Photo-Oxidation effect on their
Membranes which prohibits Biosynthesis.
Before 24 Hours 48 Hours
PROTOCOL ISUV-001-04
CLASSIFICATION BY AGE AGE GROUP SUBJECTS
18 – 30 1231 – 40 1641 – 51 8 TOTAL: 36
PROTOCOLO ISUV-001-04 STUDY DECREASE PROGRESSION
VIRAL LOAD VIRAL LOAD• ROCHE 116A (8 WEEKS) 52% 48%• ROCHE 116A (16 WEEKS) 46% 54%• ROCHE 116B/117 (8 WEEKS) 55% 45%• ROCHE 116B/117 (16 WEEKS) 55% 45%
• GMT-PCI 2004-001 (4 WEEKS) 58% 42%• GMT-PCI 2004-001 (8 WEEKS) 76% 24%• GMT-PCI 2004-001 (12 WEEKS) 84% 16%
GMT PCI REGIMENT COMPARED TO A DOUBLE BRANCH STUDY PERFORMED BY
ROCHE , UTILIZING RETROVIRAL REGIMENT OF ZDV, AND ddl.
BEFORE AND AFTER PHOTOS.AFTER 90 DAYS OF TREATMENT, 100% OF OPPORTUNISTIC INFECTIONS HAD
SUBSIDED.GMT believes it can reduce the cost to keep one HIV/AIDS patient alive by 90% a year.
Savings to Medicare and Medicaid would be in the Billions.
Current Across the Board yearly cost in US to keep 1 million HIV/AIDS patients alive = 20 Billion
Estimated cost with GMT Protocol 1 million patients
1.5 to 2 Billion
PRE TREATMENTPRE TREATMENT AFTER 2 AFTER 2 TREATMENTS.TREATMENTS.
WEEK 2WEEK 2
AFTER 4 AFTER 4 TREATMENTS.TREATMENTS.
WEEK 4WEEK 4
AFTER 2 TREATMENTS (WEEK 2)AFTER 2 TREATMENTS (WEEK 2)PRE TREATMENTPRE TREATMENT
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)PRE TREATMENTPRE TREATMENT
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2)(WEEK 2)PRE TREATMENTPRE TREATMENT